U.S. Markets closed
  • S&P Futures

    3,274.00
    -28.25 (-0.86%)
     
  • Dow Futures

    26,390.00
    -167.00 (-0.63%)
     
  • Nasdaq Futures

    11,197.50
    -145.25 (-1.28%)
     
  • Russell 2000 Futures

    1,548.90
    -9.50 (-0.61%)
     
  • Crude Oil

    36.40
    +0.23 (+0.64%)
     
  • Gold

    1,871.80
    +3.80 (+0.20%)
     
  • Silver

    23.51
    +0.15 (+0.64%)
     
  • EUR/USD

    1.1688
    +0.0010 (+0.0818%)
     
  • 10-Yr Bond

    0.8350
    +0.0540 (+6.91%)
     
  • Vix

    37.59
    -2.69 (-6.68%)
     
  • GBP/USD

    1.2936
    +0.0013 (+0.0970%)
     
  • USD/JPY

    104.4690
    -0.1410 (-0.1348%)
     
  • BTC-USD

    13,454.31
    +23.63 (+0.18%)
     
  • CMC Crypto 200

    265.74
    +23.06 (+9.50%)
     
  • FTSE 100

    5,581.75
    -1.05 (-0.02%)
     
  • Nikkei 225

    23,152.24
    -179.70 (-0.77%)
     

Zynex Inc (ZYXI) President, CEO and Chairman Thomas Sandgaard Sold $1.4 million of Shares

GuruFocus.com

President, CEO and Chairman of Zynex Inc (30-Year Financial, Insider Trades) Thomas Sandgaard (insider trades) sold 131,260 shares of ZYXI on 08/19/2019 at an average price of $10.58 a share. The total sale was $1.4 million.

Zynex Inc through its subsidiaries, designs, manufactures and sells U.S. Food and Drug Administration medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. Zynex Inc has a market cap of $333.990 million; its shares were traded at around $10.29 with a P/E ratio of 35.50 and P/S ratio of 9.38. GuruFocus has detected 1 severe warning sign with Zynex Inc. .

CEO Recent Trades:

  • President, CEO and Chairman, 10% Owner Thomas Sandgaard sold 131,260 shares of ZYXI stock on 08/19/2019 at the average price of $10.58. The price of the stock has decreased by 2.74% since.

For the complete insider trading history of ZYXI, click here

.This article first appeared on GuruFocus.